radionuclide therapy

You have access
Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with ¹³¹I-MIBG
Ari Kane, Matthew P. Thorpe, Michael A. Morse, Brandon A. Howard, Jorge D. Oldan, Jason Zhu, Terence Z. Wong, Neil A. Petry, Robert Reiman and Salvador Borges-Neto

Journal of Nuclear Medicine November 1, 2018, 59 (11) 1708-1713; DOI: https://doi.org/10.2967/jnumed.117.202150
You have access
Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid–Mediated Pretargeting: In Vivo Proof of Principle
Kristina Westerlund, Mohamed Altai, Bogdan Mitran, Mark Konijnenberg, Maryam Oroujeni, Christina Atterby, Marion de Jong, Anna Orlova, Johanna Mattsson, Patrick Micke, Amelie Eriksson Karlström and Vladimir Tolmachev

Journal of Nuclear Medicine July 1, 2018, 59 (7) 1092-1098; DOI: https://doi.org/10.2967/jnumed.118.208348
You have access
Efficacy of Radioembolization with ¹⁶⁶Ho-Microspheres in Salvage Patients with Liver Metastases: A Phase 2 Study
Jip F. Prince, Maurice A.A.J. van den Bosch, Johannes F.W. Nijsen, Maarten L.J. Smits, Andor F. van den Hoven, Stavros Nikolakopoulos, Frank J. Wessels, Rutger C.G. Bruijnen, Manon N.G.J.A. Braat, Bernard A. Zonnenberg and Marnix G.E.H. Lam

Journal of Nuclear Medicine April 1, 2018, 59 (4) 582-588; DOI: https://doi.org/10.2967/jnumed.117.197194
You have access
Optimizing Image Quantification for ¹⁷⁷Lu SPECT/CT Based on a 3D Printed 2-Compartment Kidney Phantom
Johannes Tran-Gia and Michael Lassmann

Journal of Nuclear Medicine April 1, 2018, 59 (4) 616-624; DOI: https://doi.org/10.2967/jnumed.117.200170
You have access
Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether Analog
Dana C. Baiu, Ian R. Marsh, Alexander E. Boruch, Ankita Shahi, Saswati Bhattacharya, Justin J. Jeffery, Qianqian Zhao, Lance T. Hall, Jamey P. Weichert, Bryan P. Bednarz and Mario Otto

Journal of Nuclear Medicine February 1, 2018, 59 (2) 244-250; DOI: https://doi.org/10.2967/jnumed.117.193748
You have access
Biodistribution, Pharmacokinetics, and Dosimetry of ¹⁷⁷Lu-, ⁹⁰Y-, and ¹¹¹In-Labeled Somatostatin Receptor Antagonist OPS201 in Comparison to the Agonist ¹⁷⁷Lu-DOTATATE: The Mass Effect
Guillaume P. Nicolas, Rosalba Mansi, Lisa McDougall, Jens Kaufmann, Hakim Bouterfa, Damian Wild and Melpomeni Fani

Journal of Nuclear Medicine September 1, 2017, 58 (9) 1435-1441; DOI: https://doi.org/10.2967/jnumed.117.191684
You have access
Therapeutic Radiometals Beyond ¹⁷⁷Lu and ⁹⁰Y: Production and Application of Promising α-Particle, β⁻-Particle, and Auger Electron Emitters
Cristina Müller, Nicholas P. van der Meulen, Martina Benešová and Roger Schibli

Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 91S-96S; DOI: https://doi.org/10.2967/jnumed.116.186825
You have access
¹⁷⁷Lu-PSMA Radioligand Therapy for Prostate Cancer
Wolfgang P. Fendler, Kambiz Rahbar, Ken Herrmann, Clemens Kratochwil and Matthias Eiber

Journal of Nuclear Medicine August 1, 2017, 58 (8) 1196-1200; DOI: https://doi.org/10.2967/jnumed.117.191023
You have access
Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in ¹²⁴I PET/CT–Based Dosimetry for ¹³¹I Therapy of Metastatic Differentiated Thyroid Cancer
Donika Plyku, Robert F. Hobbs, Kevin Huang, Frank Atkins, Carlos Garcia, George Sgouros and Douglas Van Nostrand

Journal of Nuclear Medicine July 1, 2017, 58 (7) 1146-1154; DOI: https://doi.org/10.2967/jnumed.116.179366
You have access
α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colon Cancer Xenografts
Sandra Heskamp, Reinier Hernandez, Janneke D.M. Molkenboer-Kuenen, Markus Essler, Frank Bruchertseifer, Alfred Morgenstern, Erik J. Steenbergen, Weibo Cai, Christof Seidl, William J. McBride, David M. Goldenberg and Otto C. Boerman

Journal of Nuclear Medicine June 1, 2017, 58 (6) 926-933; DOI: https://doi.org/10.2967/jnumed.116.187021

Main menu

User menu

Search

radionuclide therapy

Pages